Fingerprint
Dive into the research topics of 'Tristetraprolin is a prognostic biomarker for poor outcomes among patients with low-grade prostate cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Tristetraprolin is a prognostic biomarker for poor outcomes among patients with low-grade prostate cancer
Robert J. Rounbehler, Anders E. Berglund, Travis Gerke, Mandeep M. Takhar, Shivanshu Awasthi, Weimin Li, Elai Davicioni, Nicholas G. Erho, Ashley E. Ross, Edward M. Schaeffer, Eric A. Klein, R. Jeffrey Karnes, Robert B. Jenkins, John L. Cleveland, Jong Y. Park, Kosj Yamoah
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations